(Q38111597)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

misinformation correction

2 March 2020

main subject

vaccine misinformation

1 reference

based on heuristic

inferred from title

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Nathan W Stupiansky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Zeev Rosberger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

William A Fisher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Samara Perez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

31 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

414-418

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23732252%20AND%20SRC:MED&resulttype=core&format=json

Risk messages about HPV, cervical cancer, and the HPV vaccine gardasil in North American news magazines

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

The birds, the bees, and the HPVs: what drives mothers' intentions to use the HPV vaccination as a chance to talk about sex?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Risky business: challenges in vaccine risk communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Social cognitive theory: an agentic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Debunking vaccination myths: strong risk negations can increase perceived vaccination risks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Opportunities and challenges of Web 2.0 for vaccination decisions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

When vaccines go viral: an analysis of HPV vaccine coverage on YouTube

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

HPV vaccine information-seeking behaviors among US physicians: government, media, or colleagues?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Beyond cervical cancer: burden of other HPV-related cancers among men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Risk avoidance: graphs versus numbers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Protecting Public Trust in Immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Reduction of HPV infections through vaccination among at-risk urban adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Childhood vaccine risk/benefit communication in private practice office settings: a national survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Prevalence of HPV infection among females in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Human papillomavirus vaccine in adolescent women: a 2012 update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Understanding human papillomavirus vaccine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Interest in having HPV vaccination among adolescent boys in England.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Monitoring HPV16/18 immunisation in England and elsewhere.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Factors influencing familial decision-making regarding human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Human papillomavirus vaccines: current status and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Adolescent and young adult HPV vaccination in Australia: achievements and challenges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Epidemiology and pathology of HPV disease in males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Perspectives on decision making about human papillomavirus vaccination among 11- to 12-year-old girls and their mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Human papillomavirus vaccine initiation among adolescent girls in high-risk communities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

The HPV vaccine: a content analysis of online news stories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Effects of a narrative HPV vaccination intervention aimed at reaching college women: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Risk perceptions after human papillomavirus vaccination in HIV-infected adolescents and young adult women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

An analysis of the Human Papilloma Virus vaccine debate on MySpace blogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Text message reminders to promote human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Safety of quadrivalent human papillomavirus vaccine administered routinely to females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Physician attitudes and practice toward human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Human papillomavirus vaccination intentions and uptake in college women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Communicating with parents about vaccination: a framework for health professionals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Human papillomavirus vaccine and sexual behavior among adolescent and young women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Human papillomavirus vaccine discussions: an opportunity for mothers to talk with their daughters about sexual health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Parents' Internet use for information about HPV vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Reported adverse events in young women following quadrivalent human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Communicating science to the public: MMR vaccine and autism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Chapter 2: The burden of HPV-related cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Mother-daughter communication and human papillomavirus vaccine uptake by college students.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

A prospective and retrospective look at the diffusion model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Assessment of the perceptions and administration of the human papillomavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Human papillomavirus vaccine and behavioural disinhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Age-specific prevalence of human papillomavirus infection in males: a global review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Human papillomavirus vaccine and men: what are the obstacles and challenges?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Risk of female human papillomavirus acquisition associated with first male sex partner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Appropriate use of cervical cancer vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013

Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.05.013